← Back to Search

Wearable Stress Monitor for Stress Management

N/A
Waitlist Available
Led By Marie Krousel-Wood, MD, MSPH
Research Sponsored by Tulane University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >=18 years
Be older than 18 years old
Must not have
Previous diagnosis of atrial fibrillation
Unable or unwilling to give informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a wristband that tracks health data to help healthcare workers manage stress and burnout. The wristband provides real-time feedback on stress levels, aiming to improve their readiness to address burnout.

Who is the study for?
This trial is for healthcare workers at FQHC, aged 18 or older, who can understand and speak English. They must have a smartphone compatible with the Biostrap sensor and app, and be working during the six-week study. Pregnant individuals, those unable to consent, with pacemakers or diagnosed atrial fibrillation cannot join.
What is being tested?
The trial is testing if a wrist-worn sensor can help healthcare workers manage stress and burnout by providing biofeedback on their physical state. Participants will use this technology over a period of six weeks to monitor their well-being.
What are the potential side effects?
Since this intervention involves wearing a sensor and using an app rather than taking medication or undergoing medical procedures, side effects are minimal but may include discomfort from wearing the device or anxiety from monitoring symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with atrial fibrillation before.
Select...
I cannot or do not want to give permission for treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in mean in readiness to change composite score between immediate information and delayed information periods.
Secondary study objectives
Change in burnout score from baseline to 6 weeks
Other study objectives
Change in mean on participant Heart Rate Variability (HRV) between conditions
Change in mean on participant activity level score between conditions
Change in mean on participant heart rate between conditions
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Real time access start armExperimental Treatment1 Intervention
The participants will receive real-time access to their biometric data via the Biostrap API (immediate information condition). After 1 week "washout" the arms will cross-over, and the delayed access start arm will receive real-time access to their biometrics via the Biostrap API while real time access start arm is blinded to their biometric report until the end of the control period.
Group II: Delayed access start armExperimental Treatment1 Intervention
The participants are blinded to their biometrics until the control period is over (information delayed condition). After 1 week "washout" the arms will cross-over, and the delayed access start arm will receive real-time access to their biometrics via the Biostrap API while real time access start arm is blinded to their biometric report until the end of the control period.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Biofeedback, a common treatment for stress, involves monitoring physiological signals like heart rate, muscle tension, and skin temperature to help individuals gain control over these functions. By becoming aware of their stress responses, patients can learn techniques such as deep breathing, progressive muscle relaxation, and mindfulness to manage stress effectively. This approach is significant for stress patients as it empowers them to actively participate in their stress management, potentially reducing symptoms of stress and burnout.

Find a Location

Who is running the clinical trial?

Tulane UniversityLead Sponsor
121 Previous Clinical Trials
239,020 Total Patients Enrolled
Marie Krousel-Wood, MD, MSPHPrincipal InvestigatorTulane University
2 Previous Clinical Trials
106 Total Patients Enrolled
~40 spots leftby Nov 2025